Blog Elements
You can display blog posts in various ways with the “Blog Post” element/shortcode. You can see one example here and even more at the blog main menu item of this demo.
https://www.sifact.it/wp-content/uploads/2020/02/Pg-Bandi.jpg
200
800
Marina Festinese
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Marina Festinese2022-06-30 09:57:522022-06-30 12:01:11Istruzioni per l’inserimento e invio abstract 2022
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
0
0
Marco Chiumente
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Marco Chiumente2022-06-25 17:25:332022-06-25 17:25:36Oncologia, novità terapeutiche e ruolo del farmacista clinico nella gestione dei trattamenti
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
0
0
Marina Festinese
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Marina Festinese2022-06-06 16:22:392022-06-06 16:22:42Age-Adjusted Survival Extrapolations-Results May Differ From Those Generated by the Weibull Model
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
0
0
Marina Festinese
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Marina Festinese2022-06-06 16:18:592022-06-06 16:19:01Medical Therapy, Radiofrequency Ablation, or Cryoballoon Ablation as First-Line Treatment for Paroxysmal Atrial Fibrillation: Interpreting Efficacy Through the Shiny Method
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
0
0
Marina Festinese
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Marina Festinese2022-06-06 16:13:442022-06-06 16:14:53Disposal practices for unused and expired medications: pilot data from three cities in three countries
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
0
0
Marina Festinese
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Marina Festinese2022-06-06 16:05:412022-06-06 16:07:42Indirect comparison of three PARP inhibitors (olaparib, niraparib, and rucaparib) as maintenance treatment in ovarian carcinoma patients responding to platinum therapy
X Congresso SIFACT 2022